IRCT201112036027N2已完成3 期
The effect of Topiramate on weight loss in Iranian patients with diabetes type 2
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •1- patients aged 18–75 years 2-body mass index (BMI) between 27 and 50 kg/m2 3-documented history of type 2 diabetes mellitus 4- glycosylated hemoglobin (HbA1c) less than 11% 5- blood pressure (BP) less than 160/105 mmHg 6-constant weight for at least 3 months (±3 kg). Exclusion criteria: 1-History of central nervous system (CNS) related or psychiatric disorders 2-Significant renal, hepatic or thyroid disease 3- Pregnancy 4- Sever diabetes complications
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Topiramate’s effectiveness on weight reduction in overweight/obese persons with SchizophreniaSchizophrenia, Obesity, OverweightSLCTR/2017/003Department of Psychiatry
已完成
3 期
Topiramate’s effectiveness on weight reduction and metabolic syndrome in obese patients with schizophrenia and schizoaffectiveIRCT20210622051665N1niversity of social welfare and rehabilitation sciences70
已完成
不适用
Effect of Topiramate on body weight of patients with schizophrenia treated with OlanzapineSchizophrenia.SchizophreniaIRCT201402085280N15Mashhad University of Medical Sciences48
进行中（未招募）
不适用
The effect of short term Topiramate treatment on insulin secretion, glucose- and lipid metabolism in obese women - Effect of Topiramate on glucose and lipid metabolism in obese womeEUCTR2006-004373-10-NLTop institute of Pharmaceutical Research
尚未招募
4 期
The effect of short term Topiramate treatment on insulin secretion, glucose- and lipid metabolism in obese womeobesitasmetabolic syndrome10018424obesityNL-OMON31914Top Institute Pharma13